These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 13034523)

  • 1. Agranulocytosis following phenylbutazone (butazolidin) therapy; report of a fatal case.
    STEINBERG CL; BOHROD MG; ROODENBURG AI
    J Am Med Assoc; 1953 May; 152(1):33-6. PubMed ID: 13034523
    [No Abstract]   [Full Text] [Related]  

  • 2. Agranulocytosis following phenylbutazone (Butazolidin).
    BRANDWEIN S
    N Y State J Med; 1953 Jul; 53(13):1577-8. PubMed ID: 13072836
    [No Abstract]   [Full Text] [Related]  

  • 3. Agranulocytosis with recovery following the use of phenylbutazone (Butazolidin).
    ARCHER BH; KANTOR MG
    N Y State J Med; 1954 Feb; 54(3):394-5. PubMed ID: 13133104
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal case of agranulocytosis following phenylbutazone.
    WOOD IH
    Br Med J; 1954 Apr; 1(4865):802. PubMed ID: 13140868
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatal agranulocytosis and gastric ulceration due to phenylbutazone.
    DILLING NV
    Lancet; 1953 Jun; 1(6773):1230-1. PubMed ID: 13053735
    [No Abstract]   [Full Text] [Related]  

  • 6. Agranulocytosis following use of phenylbutazone (butazolidin); report of a case.
    HINZ C; LAMONT-HAVERS RW; COMINSKY B; GAINES LM
    J Am Med Assoc; 1953 Jan; 151(1):38-9. PubMed ID: 12999503
    [No Abstract]   [Full Text] [Related]  

  • 7. Agranulocytosis caused by phenylbutazone and 4-amino-antipyrine.
    KIELY JM; STICKNEY JM
    Proc Staff Meet Mayo Clin; 1953 Jun; 28(12):341-5. PubMed ID: 13056023
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatality due to agranulocytosis following use of phenylbutazone (butazolidin).
    ETESS AD; JACOBSON AS
    J Am Med Assoc; 1953 Feb; 151(8):639-40. PubMed ID: 13011064
    [No Abstract]   [Full Text] [Related]  

  • 9. Agranulocytosis following use of phenylbutazone (butazolidin).
    BERSHOF E; OXMAN AC
    J Am Med Assoc; 1953 Feb; 151(7):557-8. PubMed ID: 13011049
    [No Abstract]   [Full Text] [Related]  

  • 10. Agranulocytosis following administration of phenylbutazone (butazolidin).
    STIFEL JL; BURNHEIMER JC
    J Am Med Assoc; 1953 Feb; 151(7):555-6. PubMed ID: 13011047
    [No Abstract]   [Full Text] [Related]  

  • 11. [Agranulocytosis after irgapyrin therapy].
    SALLSTRAND M
    Sven Lakartidn; 1953 Jun; 50(25):1363-4. PubMed ID: 13090113
    [No Abstract]   [Full Text] [Related]  

  • 12. Death from hypersensitivity due to phenylbutazone.
    O'BRIEN DJ; STOREY G
    Br Med J; 1954 Apr; 1(4865):792-4. PubMed ID: 13140863
    [No Abstract]   [Full Text] [Related]  

  • 13. Deaths of two patients treated by phenylbutazone.
    BENSTEAD JG
    Br Med J; 1953 Mar; 1(4812):711-2. PubMed ID: 13032466
    [No Abstract]   [Full Text] [Related]  

  • 14. Perforated duodenal ulcer with neutropenia and death in a patient receiving phenylbutazone therapy.
    BEUTLER E; BERGENSTAL DM
    Gastroenterology; 1953 Sep; 25(1):72-4. PubMed ID: 13095677
    [No Abstract]   [Full Text] [Related]  

  • 15. Stevens-Johnson syndrome and granulocytopenia after phenylbutazone.
    STEEL SJ; MOFFATT JL
    Br Med J; 1954 Apr; 1(4865):795. PubMed ID: 13140864
    [No Abstract]   [Full Text] [Related]  

  • 16. RISKS of butazolidin therapy.
    Br Med J; 1953 Jan; 1(4804):267. PubMed ID: 13009173
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal agranulocytosis following phenylbutazone (butazolidin) therapy; report of case with autopsy findings.
    STEIN T
    J Med Assoc State Ala; 1954 Oct; 24(4):87-92. PubMed ID: 13201907
    [No Abstract]   [Full Text] [Related]  

  • 18. Agranulocytosis following phenylbutazone therapy.
    WERBLOW SC; NEBER J
    J Am Med Assoc; 1953 Apr; 151(15):1286-9. PubMed ID: 13034473
    [No Abstract]   [Full Text] [Related]  

  • 19. Agranulocytosis due to phenylbutazone.
    GEESAMAN RE; JAMES FL
    Ann Intern Med; 1957 Jan; 46(1):152-5. PubMed ID: 13395226
    [No Abstract]   [Full Text] [Related]  

  • 20. Exfoliative dermatitis following ingestion of phenylbutazone (butazolidin).
    FISHMAN HC; REYNOLDS J
    J Am Med Assoc; 1953 Oct; 153(7):642-3. PubMed ID: 13084438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.